Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-002577

Chief Financial Officer sold 30,625 shares at an average $72.44 ($2,218,477)

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-06 Sale : show line 1 in the form −1,100 $70.75 $77,825 486,568 D
2021-01-06 Sale : show line 2 in the form −4,359 $71.77 $312,845 482,209 D
2021-01-06 Sale : show line 3 in the form −25,166 $72.63 $1,827,807 457,043 D
Open-market sales · 30,625 sh · avg $72.44 · $2,218,477
Loading xslF345X03/doc4.xml…